Excalibur Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Excalibur Management's LLY Position: Q2 2026 in Review
Excalibur Management reduced its Eli Lilly (LLY) stake by 3.3% in Q2 2026, selling an estimated $48K and leaving 1,361 shares worth $1.63M. The position accounts for 0.54% of the portfolio, ranked #50.
Excalibur Management first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Excalibur Management held 1,361 shares of Eli Lilly worth $1.63M as of Q2 2026.
- Excalibur Management sold 47 Eli Lilly shares in Q2 2026, an estimated $48K.
- Eli Lilly made up 0.54% of Excalibur Management's portfolio in Q2 2026, its #50 holding.
- Excalibur Management first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Excalibur Management's 13F filing for Q2 2026, filed 3 Aug 2026.